News Detail

Date/Time
12 Apr 2022 17:08:00
Headline
Notification the final exercise and request for suspension of VIBHA-W3
Symbol
VIBHA
Source
VIBHA
Full Detailed News
Download Full Detailed News
                Notification the exercise of securities/ Notification the conversion of 
securities

Subject                                  : Notification the Final Exercise of 
securities
Date announced                           : 01-Apr-2022
Name of securities                       : VIBHA-W3
Exercise date                            : 14-Jun-2022
Book closing date of warrant             : From 24-May-2022 to 14-Jun-2022
registration (Update)
Date of request to post "SP" sign        : From 20-May-2022 to 14-Jun-2022
(Update)
The notification period for the exercise : From 30-May-2022 to 13-Jun-2022
 of the securities
Exercise price (baht per share)          : 2.993
Exercise ratio (Warrants : common        : 1 : 1.0023
shares)
Delisting date                           : 15-Jun-2022
Exercise Procedure                       : https://www.vibhavadi.com/ir-news
Contact Persons and Place to Exercise    : Meeting Room 4th floor, Building 2 
Tower A.
Vibhavadi Medical Center Public Company Limited
51/3 Ngarmvongvan Road, Lad Yao, Chatuchak Bangkok 10900
Tel. 0-2561-1111 ext. 2427 Fax. 0-2561-1462
Authorized to sign on behalf of the      : Mr. Phijit Viriyamettakul
company
Position                                 : Managing Director
______________________________________________________________________
This announcement was prepared and disseminated by listed company or issuer 
through the electronic system which is provided for the purpose of dissemination
of the information and related documents of listed company or issuer to the
Stock Exchange of Thailand only.  The Stock Exchange of Thailand has   no
responsibility for the correctness and completeness of any statements, figures,
reports or opinions contained in this announcement, and has no liability for any
losses and damages in any cases.  In case you have any inquiries or
clarification regarding this announcement, please directly contact listed
company or issuer who made this announcement.